(NASDAQ: IART) Integra Lifesciences Holdings's forecast annual revenue growth rate of 3.77% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.23%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.32%.
Integra Lifesciences Holdings's revenue in 2025 is $1,624,308,000.On average, 6 Wall Street analysts forecast IART's revenue for 2025 to be $130,013,566,949, with the lowest IART revenue forecast at $129,585,216,895, and the highest IART revenue forecast at $130,556,620,320. On average, 6 Wall Street analysts forecast IART's revenue for 2026 to be $135,946,044,234, with the lowest IART revenue forecast at $135,360,793,099, and the highest IART revenue forecast at $136,830,332,200.
In 2027, IART is forecast to generate $141,776,718,440 in revenue, with the lowest revenue forecast at $141,094,404,674 and the highest revenue forecast at $142,427,947,296.